OCTIMET ONCOLOGY
OCTIMET oncology’s overall strategy is to advance the development of discovery stage molecules by employing innovative patient selection and pharmacodynamic biomarker-based strategies, as well as an innovative clinical development strategy.
OCTIMET ONCOLOGY
Industry:
Biotechnology Medical
Founded:
2016-01-01
Address:
Beerse, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.octimet.com
Total Employee:
11+
Status:
Active
Contact:
+32473558353
Email Addresses:
[email protected]
Total Funding:
12.38 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx Microsoft Exchange Online
Similar Organizations
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Oxford Cannabinoid Technologies
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Flanders Innovation and Entrepreneurship (VLAIO)
Flanders Innovation and Entrepreneurship (VLAIO) investment in Grant - OCTIMET Oncology
Fund+
Fund+ investment in Series A - OCTIMET Oncology
V-Bio Ventures
V-Bio Ventures investment in Series A - OCTIMET Oncology
Omnes Capital
Omnes Capital investment in Series A - OCTIMET Oncology
Droia Ventures
Droia Ventures investment in Series A - OCTIMET Oncology
Official Site Inspections
http://www.octimet.com
- Host name: linweb122.webhosting.be
- IP address: 185.162.30.91
- Location: Brussels Belgium
- Latitude: 50.8336
- Longitude: 4.3337
- Timezone: Europe/Brussels
- Postal: 1060
More informations about "OCTIMET Oncology" on Search Engine
OCTIMET
OCTIMET oncology’s overall strategy is to develop cMET inhibitor and other highly selective anti-tumour molecules by employing innovative patient selection and pharmacodynamic biomarker-based strategies, as …See details»
OCTIMET Oncology - Crunchbase Company Profile
Contact Email [email protected]. Phone Number +32473558353. OCTIMET oncology’s overall strategy is to advance the development of discovery stage molecules by …See details»
Octimet Oncology Company Profile 2024: Valuation, …
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most. Information on valuation, funding, cap tables, …See details»
OCTIMET Oncology NV | LinkedIn
Beerse, 2340, BE. Get directions. Employees at OCTIMET Oncology NV. Christina Takke. OCTIMET Oncology NV | 495 followers on LinkedIn. OCTIMET oncology was founded …See details»
OCTIMET Oncology tackling cancer with a new captain at the helm
May 29, 2019 In this article, V-Bio Ventures introduces one of their portfolio companies, OCTIMET. This Belgian oncology startup just added a new member to its executive …See details»
OCTIMET Oncology Company Profile - Craft
OCTIMET Oncology has 5 employees across 2 locations and $13.41 m in total funding,. See insights on OCTIMET Oncology including office locations, competitors, revenue, …See details»
About OCTIMET Oncology - Biotech company in …
Biotech. About Investors. Overview. Gent, Belgium. Founded 2016. Raised from Fund+ and 3 more See all investors. octimet.com. About OCTIMET Oncology.See details»
Octimet bags €11m for development of cancer drugs
Jan 19, 2017 Belgian start-up company Octimet Oncology NV has secured €11.3m in a series A financing round. The funds will be used to develop two MET kinase blockers to …See details»
OCTIMET Oncology NV secures over EUR 11 million to develop …
Jan 18, 2017 Octimet Oncology announced today that it has completed its series A investment round. The cancer start-up was able to secure €11.3 million from an …See details»
OCTIMET expands ongoing proof of concept study to evaluate …
Sep 25, 2019 OCTIMET Oncology NV acts as a translational accelerator, focusing on creating value for patients and investors by providing rapid clinical proof of concept for …See details»
OCTIMET Oncology - Products, Competitors, Financials, …
OCTIMET primarily sells to sectors involved in oncology drug development and clinical research. It is based in Beerse, Belgium. Headquarters Location. Turnhoutsebaan 30. …See details»
OCTIMET partners OMO-1 and OMO-2 with Shanghai Allist …
GEEL, Belgium, Sept. 16, 2020 /PRNewswire/ -- OCTIMET Oncology NV, a clinical-stage Belgian life science company with a focus on the development of highly selective, …See details»
OCTIMET secures over EUR 11 million to develop its highly …
Jan 19, 2017 OCTIMET oncology NV, has secured EUR 11.3 million in a Series A investment round, enabling the company to accelerate the development of a clinically de …See details»
Octimet closes $12M series A round for oral Met inhibitor
Jan 20, 2017 BioWorld. DUBLIN – Octimet Oncology NV, a spinout from the Janssen Pharmaceutica NV arm of Johnson & Johnson, raised €11.3 million (US$12 million) in a …See details»
OCTIMET Oncology - Funding, Financials, Valuation & Investors
Highlights. Funding Rounds 2. Total Funding Amount. Unlock for free. Lead Investors 3. Investors 5. Funding. OCTIMET Oncology has raised a total of. €12.4M. in funding over …See details»
FDA Approves OCTIMET’s evaluation OMO-1 in patients
Jan 29, 2019 OCTIMET Oncology NV, a Belgian clinical-stage biotech company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted its …See details»
OCTIMET Oncology - Contacts, Employees, Board Members, …
Contacts 1. About. OCTIMET Oncology has 3 current employee profiles, including COO Thomas Stöhr. OCTIMET Oncology has 6 board members and advisors, including …See details»
OCTIMET Oncology NV - Beerse, Belgium - bionity.com
2340 Beerse. Belgium. +32 473 558 353. octimet.com. Profile Products News. Contact. About OCTIMET Oncology. OCTIMET oncology was founded in 2016 by Timothy …See details»
OCTIMET have now partnered OMO-1 and OMO-2 with …
OCTIMET Oncology NV. Shelley Margetson, CEO. Email: [email protected]. Pieter Van Reysschootlaan 2/104. 9051 Sint-Denijs-Westrem (Gent) Belgium.See details»
OCTIMET Oncology | CipherBio
39022. Fundraising Events. Get CipherBio PRO. Request PRO Demo. Get access to curated funding data. Weekly Email Digest. By signing up, you agree to the Terms and …See details»